Results 161 to 170 of about 20,681,672 (284)

Nutrient/TOR signaling controls adipose mitochondrial transcription factor A (TFAM) to regulate organismal growth in Drosophila

open access: yesFEBS Letters, EarlyView.
Animals must match their growth rate to available nutrients. We show that in Drosophila larvae, the nutrient‐sensing TOR kinase controls growth by regulating levels of TFAM, a key regulator of mitochondrial function, in the adipose tissue. When nutrients are abundant, high TOR activity suppresses TFAM, lowering mitochondrial bioenergetic activity and ...
Shrivani Sriskanthadevan‐Pirahas   +4 more
wiley   +1 more source

Tractor Testing; Belt Test; Allis Chalmers

open access: yes, 1948
Official belt test no. 397 Allis-Chalmers HD19." The Allis-Chalmers HD-19 crawler on berlt power test inside the tractor test lab. Technician Joe Flamm stands measuring belt speed with a hand-held tachometer.
Nebraska Tractor Test Laboratory
core  

Peripheral lysosomes recruit PLEKHG3 to focal adhesions and restrain protrusion dynamics

open access: yesFEBS Letters, EarlyView.
Proximity‐dependent labeling at the LAMTOR complex revealed the Rho GEF PLEKHG3 as a lysosome‐proximal protein directing the study toward the influence of lysosome positioning on actin dynamics and cell motility. We show that PLEKHG3 colocalizes with lysosomes at focal adhesion sites and observe that forced peripheral dispersion of lysosomes hinders ...
Rainer Ettelt   +8 more
wiley   +1 more source

Test no. 394 Massey-Harris 55. 1948.

open access: yes, 1948
Three-quarter view from the front of the Massey-Harris tractor on the test track.
Nebraska Tractor Test Laboratory
core  

Periprosthetic joint infection: patients benefit from a multidisciplinary team approach

open access: yesBone & Joint Research, 2022
Nike Walter   +7 more
doaj   +1 more source

Can the Immune System Perform a t-Test? [PDF]

open access: yesPLoS One, 2017
Faria BF   +2 more
europepmc   +1 more source

Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation

open access: yesFEBS Letters, EarlyView.
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy